What it is
Autosomal recessive disorder caused by pathogenic variants in the CFTR gene (cystic fibrosis transmembrane conductance regulator), which encodes a chloride and bicarbonate channel expressed in epithelial cells, and follow the diagnosis criteria. Diagnosis requires evidence of CFTR dysfunction, defined as a sweat chloride concentration of 60 mmol/L or greater, or identification of two CF-causing CFTR pathogenic variants, or an abnormal nasal potential difference measurement. CF is a progressive, multi-organ disease characterized by chronic obstructive lung disease with recurrent infections, exocrine pancreatic insufficiency, intestinal obstruction (including meconium ileus in neonates), male infertility due to obstructive azoospermia, hepatobiliary complications, and elevated sweat chloride concentrations.
Cystic fibrosis (CF) is an inherited disease of the mucus and sweat glands. It affects mostly your lungs, pancreas, liver, intestines, sinuses, and sex organs. CF causes your mucus to be thick and sticky. The mucus clogs the lungs, causing breathing problems and making it easy for bacteria to grow. This can lead to repeated lung infections and lung damage. The symptoms and severity of CF can vary. Some people have serious problems from birth. Others have a milder version of the disease that doesn't show up until they are teens or young adults. Read more at MedlinePlus.
Source: Monarch Initiative, MONDO:0009061 and MedlinePlus, fetched 2026-11-10.
Causes
Gene associations arrive in a later milestone.
MedlinePlus has a plain-language page on causes and risk factors: Cystic Fibrosis.
Source: MedlinePlus, fetched 2026-11-10.
Approved treatments
19 drugs whose FDA (United States) label names this disease under indications. Approval elsewhere differs.
- Acetylcysteine
dosis of the lung) Acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) Pulmonary complications of cystic fibrosis Tracheostomy care Pulmonary complications associated with surgery Use during anesthesia Post-traumatic chest conditions Atelectasis due to mucous obstruction Diagnostic bronchial studi
- Azithromycin
te for oral therapy because of moderate to severe illness or risk factors such as any of the following: • patients with cystic fibrosis, • patients with nosocomial infections, • patients with known or suspected bacteremia, • patients requiring hospitalization, • elderly or debilitated patients, or • patients with signi
- Azithromycin Dihydrate
iate for oral therapy because of moderate to severe illness or risk factors such as any of the following: patients with cystic fibrosis, patients with nosocomial infections, patients with known or suspected bacteremia, patients requiring hospitalization, elderly or debilitated patients, or patients with significant und
- Azithromycin Monohydrate (Azithromycin)
iate for oral therapy because of moderate to severe illness or risk factors such as any of the following: patients with cystic fibrosis, patients with nosocomial infections, patients with known or suspected bacteremia, patients requiring hospitalization, elderly or debilitated patients, or patients with significant und
- Aztreonam (Cayston)
CAYSTON ® is indicated to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa . Safety and effectiveness have not been established in pediatric patients below the age of 7 years, patients with FEV 1 <25% or >75% predicte
- Brensocatib (Brinsupri)
BRINSUPRI is indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older. BRINSUPRI is a dipeptidyl peptidase 1 (DPP1) inhibitor indicated for the treatment of non-cystic fibros
- Dornase Alfa (Pulmozyme)
LMOZYME ® is indicated, in conjunction with standard therapies, for the management of pediatric and adult patients with cystic fibrosis (CF) to improve pulmonary function. In CF patients with an FVC ≥ 40% of predicted, daily administration of PULMOZYME has also been shown to reduce the risk of respiratory tract infecti
- Elexacaftor, Tezacaftor, And Ivacaftor (Trikafta)
TRIKAFTA is indicated for the treatment of cystic fibrosis (CF) in adult and pediatric patients aged 2 years and older who have a clinical diagnosis of CF and who have at least one variant in the cystic fibrosis transmembrane conductance regul
- Ivacaftor (Kalydeco)
KALYDECO is indicated for the treatment of cystic fibrosis (CF) in patients aged 1 month and older who have at least one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data [see C
- Lumacaftor And Ivacaftor (Orkambi)
ORKAMBI is indicated for the treatment of cystic fibrosis (CF) in patients aged 1 year and older who are homozygous for the F508del mutation in the CFTR gene. If the patient's genotype is unknown, an FDA-cleared CF mutation test should be use
- Phytonadione (Phytonadione Phytonadione)
itamin K, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with phytonadione injectable emulsio
- Tezacaftor And Ivacaftor (Symdeko)
SYMDEKO is indicated for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR
- Tobramycin
Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients wi
- Tobramycin Inhalation
Tobramycin Inhalation Solution is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa . Safety and efficacy have not been demonstrated in patients under the age of six years, patients with FEV 1 less than 40% or greater than 80% pred
- Tobramycin Inhalation Solution
Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients wit
- Tobramycin Solution (Tobramycin)
Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients wi
- Vanzacaftor, Tezacaftor, And Deutivacaftor (Alyftrek)
ALYFTREK is indicated for the treatment of cystic fibrosis (CF) in adult and pediatric patients 6 years of age and older who have a clinical diagnosis of CF and who have at least one variant in the cystic fibrosis transmembrane conductance reg
- Vitamin K1 - Phytonadione
itamin K, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism, e.g., sal
- Vitamin K1, Phytonadione (Vitamin K1 Phytonadione)
itamin K, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism, e.g., sal
Source: openFDA drug labels, fetched 2026-11-10.
Latest research
The newest randomized trials, meta-analyses and systematic reviews with this disease in the title. 1750 in total.
- Exhaled breath volatile organic compounds in cystic fibrosis: a systematic review
- Postprandial ultra-fast insulin versus mealtime fast-acting insulin in adults with cystic fibrosis-related diabetes: A randomized multicentre crossover trial
- Population Pharmacokinetic Analysis of Brensocatib in Adult and Adolescent Patients With Non-Cystic Fibrosis Bronchiectasis
- Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
- Nucleic acid-based therapies for people with cystic fibrosis
- Participants' experiences of living with cystic fibrosis related diabetes and using a hybrid closed-loop system to support self-management: qualitative study
- The prevalence of obstructive sleep apnea-hypopnea syndrome in patients with cystic fibrosis: An updated systematic review and meta-analysismeta-analysis
- The Impact of Exercise Intervention on Pulmonary and Physical Function in Patients With Cystic Fibrosis: <i>A Comprehensive Systematic Review</i>
- The effect of harmonica-based breathing and airway clearance exercises on pulmonary function in children with cystic fibrosis: A randomized controlled trial
- CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)
- Safety and extrapulmonary effects of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis following lung transplantation: A systematic review and meta-analysis
- Automated Insulin Delivery Systems in Cystic Fibrosis-Related Diabetes: A Systematic Review and Meta-Analysis
- Cystic Fibrosis and Digital Technology: A Systematic Review
- Stress management reduces severe depression and anxiety symptoms in adults with cystic fibrosis: Results from the coping and learning to manage stress (CALM) intervention
- Phage therapy in people with cystic fibrosis: A systematic review
- Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR/TEZACAFTOR/IVACAFTOR
- Short and long-term effects of a play-based therapeutic exercise programme in children with non-cystic fibrosis bronchiectasis: A randomised controlled trial
- Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy
- Detection of Pseudomonas aeruginosa in cystic fibrosis after initiation of CFTR modulators: a systematic review
- Efficacy of Antiinflammatory Therapies for Adults With Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Network Meta-Analysis
Source: Europe PMC, fetched 2026-11-10.
Trials recruiting now
184 studies on ClinicalTrials.gov are recruiting (151) or about to (33). Most advanced first. Phase 3 is the last step before approval; Phase 1 is the first time in people.
Phase 4 8 Phase 3 5 Phase 2/3 1 Phase 2 18 Phase 1/2 2 Phase 1 13 Early phase 1 4 No phase given 46 Observational 87
Loading all 184 trials for filtering…
Phase 4, after approval 8
- Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis
- Azithromycin to Modify Bronchiectasis Exacerbation Risk
- Ensuring Access to Optimal Therapy in CF: The ENACT Study
- Hypertonic Saline in NCFB
- Estrogen Supplementation and Bone Health in Women With CF
- Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- Markers of Osteoporosis in Cystic Fibrosis
- Iron Repletion in Cystic Fibrosis
Phase 3 5
- A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
- Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
- A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
- Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis Exacerbations
- Long-Term Safety and Efficacy of Moxifloxacin in Bronchiectasis Patients
Phase 2 18
- A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
- A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
- Phase 2 Study to Assess the Safety and Efficacy of ANG003
- Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.
- Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
- Study With Phage for CF Subjects With Pseudomonas Lung Infection
- Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
- Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
- Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis
- A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
- Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
- 4D-710 in Adult Patients With Cystic Fibrosis
- Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
- GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
- Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
- Verapamil Effect in Cystic Fibrosis-related Dysglycemia
Phase 1/2 2
Phase 1 13
- Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection
- Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Participants
- Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal Impairment
- Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Hepatic Impairment
- Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants
- Evaluation of VX-581 in Healthy Participants and in Participants With Cystic Fibrosis
- Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis
- A Study Assessing KB407 for the Treatment of Cystic Fibrosis
- Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis
- IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
- Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet
- Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections
Early phase 1 4
No phase given 46
- Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
- Autogenic Drainage Versus Mechanical Percussion in Children With Cystic Fibrosis
- Diagnostic Value of Oropharyngeal Suction and Effect of Respiratory Physiotherapy on the Detection of Microorganisms in the Pediatric Patient
- High-Intensity Interval Exercise in Bronchiectasis Patients
- CF Wellness Program
- ACT With CF Self-Help Toolkit
- Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor
- Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis
- The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program
- Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
- Evaluation of New Device for Beta-adrenergic Sweat Test in the Context of Stratification of Patient With Cystic Fibrosis
- Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
- Impact of a Coordinated Dietetic-adapted Physical Activity Program on the Percentage of Lean Body Mass in Adults With Cystic Fibrosis Treated With Elexacaftor-Tezacaftor-Ivacaftor: Multicentre Randomised Controlled Trial
- GERD in Children With Cystic Fibrosis
- e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
- Acoustic Waveform Respiratory Evaluation
- A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
- Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
- Breathing Training and Exercise Capacity in Non-CFB
- Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis
- Lung Transplant READY CF 2: CARING CF Ancillary RCT
- The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
- FEED-Cystic Fibrosis (FEED-CF)
- Cystic Fibrosis in the Kidney: Monitoring the Effectiveness of Elexacaftor/tezacaftor/ivacaftor in Urine After a Short Pause of Therapy
- ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
- Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine
- Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor
- Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials
- Exercise in Child Health
- Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- Management of Breast Fibroadenoma: Comparing Observation, Microwave Ablation, and Surgical Excision
- Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function
- Reproducibility of Continuous Glucose Monitoring (CGM) in the Assessment of Glucose Metabolism Disorders in Children With Cystic Fibrosis
- Nutrition Supplement for Cystic Fibrosis
- SPutum Induction and Nebuliser deviCEs for Patients With CF
- Rethinking Early Airway Clearence Therapies
- MRI Parameters as Biomarkers in Cystic Fibrosis (FEMPTO)
- HFCWO in Children With Non-CF Bronchiectasis
- Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases
- Tele-Rehabilitation in Adults With Cystic Fibrosis
Showing the 40 most recent of 46. See every one on ClinicalTrials.gov.
Observational, no treatment given 87
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
- PERCE-MUCO: Perceptions and Expectations of People With Cystic Fibrosis Regarding a Change in Treatment
- GRAnulomatous MAstitis REGistry Study
- Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
- Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)
- Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households
- Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population
- ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health
- Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.
- Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis
- Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
- Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis
- Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
- A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine
- Physical Impairments in Children With Cystic Fibrosis
- Bronchiectasis Phenotype Identification Model
- BASE: Bronchiectasis Severity and Exacerbation Risk Study
- 19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease
- A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring
- TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
- Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
- Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association.
- Remote Sputum Collection in Cystic Fibrosis
- Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
- Kidney Function in People With Cystic Fibrosis in the Era of HEMT
- Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
- Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients
- A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis
- Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis
- Establishment of a Primary Epididymal Cell Model From Epididymal Samples to Study CFTR Gene Regulation
- A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related Disorders
- Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
- Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis
- French Validation of the AdT-Physio Scale
- CFTR Modulators in Pregnancy and Postpartum
- MAGNIFY - Pulmonary Magnetic Resonance Imaging for Cystic Fibrosis
Showing the 40 most recent of 87. See every one on ClinicalTrials.gov.
Source: ClinicalTrials.gov, fetched 2026-11-10.
Where to go
Institutions running these trials, by country. The country picker in the trials section narrows this list too.
🇺🇸United States557
Boston
- Boston Children's Hospital 9
- Massachusetts General Hospital 6
- Boston Children's Hospital, Brigham & Women's Hospital 2
- Boston Children's Hospita 1
- Massachusetts General Hospital- 55 Fruit St 1
- Boston Children'S Hospital 1
- Diabetes Research Center, Massachusetts General Hospital 1
- Boston Children's Hospital & Harvard University 1
- Massachusetts 1
- Boston Children's Hospital/Brigham and Women's Hospital 1
- Boston Children's 1
Philadelphia
- University of Pennsylvania 6
- Children's Hospital of Philadelphia 4
- Temple University Hospital 1
- The Hospital of the University of Pennsylvania 1
- Hospital at University of Pennsylvania 1
- Hospital of University of Pennsylvania 1
- University of Pennsylvania Center for Human Phenomic Science (CHPS) 1
- Thomas Jefferson University Hospital 1
- Children's Hospital of Philadelphia & University of Pennsylvania 1
- Children's Hospital of Philadelphia and University of Pennsylvania 1
- The Children's Hospital of Philadelphia 1
- The Children's Hopsital of Philadelphia 1
- The University of Pennsylvania 1
Kansas City
- University of Kansas Medical Center 12
- Children's Mercy Kansas City 2
- The University of Kansas Medical Center 1
- University of Kansas Medical Center-Kansas City 1
- Children's Mercy Hospital 1
- Kansas University Medical Center 1
Birmingham
- University of Alabama at Birmingham 7
- The Children's Hospital Alabama, University of Alabama at Birmingham 4
- The University of Alabama at Birmingham 1
- Kirklin Clinic of UAB Hospital 1
- University of Alabama Child Health Research Unit 1
- The Children's Hospital Alabama & University of Alabama at Birmingham 1
- University of Alabama-Birmingham 1
- University of Alabama at Birmingham (UAB)/Children's of Alabama 1
Seattle
- Seattle Children's Hospital 8
- University of Washington Medical Center 4
- University of Washington 2
- University of Washington Medical Center - Montlake 1
Dallas
- University of Texas Southwestern / Children's Health 5
- University of Texas Southwestern 4
- UT Southwestern Medical Center 1
- The University of Texas Southwestern Medical Center 1
- University of Texas Southwestern & Children's Health 1
- University of Texas Southwestern Medical Center 1
- University of Texas-Southwestern 1
Minneapolis
- University of Minnesota 5
- The Minnesota Cystic Fibrosis Center 5
- Children's Hospitals and Clinics of Minnesota 3
- The Minnesota Cystic Fibrosis Center & University of Minnesota 1
Baltimore
- Johns Hopkins University 5
- John Hopkins Hospital 3
- Johns Hopkins 1
- Johns Hopkins Medicine - Pulmonary and Critical Care 1
- Johns Hopkins Hospital 1
- Johns Hopkins Hospital, Johns Hopkins University 1
- Johns Hopkins Pediatric Diabetes Center 1
Atlanta
- Emory University 2
- Children's Healthcare of Atlanta and Emory University 2
- Emory-Children's Healthcare of Atlanta Cystic Fibrosis Center 1
- Emory University at Saint Joseph Pulmonary Clinic 1
- Children's Healthcare of Atlanta & Emory University 1
- Emory University Hospital 1
- Adult Cystic Fibrosis Clinic 1
- Arthur M. Blank Hospital | Children's Healthcare of Atlanta 1
- Emory University School of Medicine 1
- Emory University/Children's Hospital of Atlanta (CHOA) 1
- Emory 1
Cincinnati
- Cincinnati Children's Hospital Medical Center 7
- University of Cincinnati Medical Center 1
- Cincinnati Children's Hospital 1
- CCHMC 1
- University of Cincinnati 1
- Penny New 1
- Cincinnati Children's 1
Denver
- National Jewish Health 12
- National Jewish Health Main Campus 1
Pittsburgh
- University of Pittsburgh Medical Center 5
- Children's Hospital of Pittsburgh of UPMC 3
- University of Pittsburgh 3
- Children's Hospital of Pittsburgh of UPMC & University of Pittsburgh Medical Center 1
Los Angeles
- Childrens Hospital Los Angeles 2
- Children's Hospital Los Angeles 1
- Keck Hospital of USC 1
- Cedars Sinai Medical Center - Inflammatory Bowel Disease Ctr 1
- Center for Cystic Fibrosis at Keck Medical Center of USC 1
- Children's Hospital of Los Angeles 1
- So Cal Institute for Respiratory Diseases, Inc. 1
- University of Southern California 1
- Children's Hospital of Los Angeles & Anton Yelchin Cystic Fibrosis Clinic 1
- Keck Medical Center of USC 1
- University of California, Los Angeles 1
Chapel Hill
- University of North Carolina at Chapel Hill 6
- University of North Carolina 3
- University of North Carolina School of Medicine 1
- Univeristy of North Carolina at Chapel Hill 1
St Louis
- Washington University School of Medicine 6
- St. Louis Children's Hospital 2
- SSM Health Cardinal Glennon Children's Hospital 1
- St. Louis Children's Hospital & Washington University School of Medicine 1
- Washington University at St. Louis 1
Columbus
- Nationwide Children's Hospital 7
- The Ohio State University College of Medicine (OSUCOM) 1
- Nationwide Children's Hospital, Columbus 1
- Ohio State University 1
- Nationwide Children's Hospital-Ohio State University 1
Charleston
- Medical University of South Carolina 10
- Medical University of South Carolina (MUSC) - PPDS 1
Indianapolis
- Riley Hospital for Children 4
- Indiana University 3
- Indiana University Medical Center 1
- Indiana University Health 1
- Riley Hospital for Children & Indiana University 1
Portland
- Oregon Health Sciences University 2
- Oregon Health and Science University 2
- Oregon Health & Sciences University 2
- Maine Medical Center 1
- MaineHealth Pediatric Specialty Care 1
- Oregon Health & Science University 1
- Oregon Health Science University 1
Ann Arbor
- University of Michigan, Michigan Medicine 5
- University of Michigan 3
- University of Michigan Hospital 1
- University of Michigan Health System 1
New York
- Children's Hospital of New York 2
- Columbia University Cystic Fibrosis Program 2
- Lenox Hill Hospital Cystic Fibrosis Center 1
- Columbia University Irving Medical Center 1
- Northwell Health 1
- NYU Langone Health Pulmonary and Critical Care Associates, P.C. - BRANY - PPDS 1
- Columbia University 1
- Northwell Health Physicians 1
Aurora
- Children's Hospital Colorado 6
- Children's Hospital of Colorado 2
- University of Colorado Denver 1
- University of Colorado 1
Iowa City
- University of Iowa 8
Cleveland
- Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center 5
- University Hospitals Cleveland Medical Center/Rainbow Babies & Children's Hospital 1
- Cleveland Clinic Foundation 1
- Cleveland Clinic Cystic Fibrosis Program 1
Orlando
- Central Florida Pulmonary Group 3
- Advent Health Medical Group 1
- Nemours Foundation 1
- Nemours Children's 1
- The Nemours Children's Clinic - Orlando 1
Tucson
- Tucson Cystic Fibrosis Center 4
- University of Arizona 1
- The University of Arizona 1
Gainesville
- University of Florida 4
- University of Florida, Gainesville 1
- Shands at the University of Florida 1
Miami
- University of Miami 5
- University of Miami Hospital 1
Chicago
- Ann & Robert H. Lurie Children's Hospital of Chicago 2
- Northwestern University 2
- Northwestern Memorial Hospital 1
- Ann & Robert H. Lurie Children's Hospital of Chicago & Northwestern University 1
Nashville
- Vanderbilt University Medical Center 4
- Vanderbilt Children's Hospital 1
- Vanderbilt University Medical Center - Pulmonary Hospital - University 1
Richmond
- Virginia Commonwealth University 4
- Virginia Commonwealth University Health System 1
- Children's Hospital of Richmond at Virginia Commonwealth University 1
Madison
- University of Wisconsin 6
Hershey
- Hershey Medical Center Pennsylvania State University 3
- Penn State Health 2
- Penn State Milton S. Hershey Medical Center 1
Salt Lake City
- University of Utah 3
- Adult Cystic Fibrosis Center at the University of Utah 2
- Primary Children's Cystic Fibrosis Center 1
Palo Alto
- Stanford University 3
- Stanford University Medical Center 3
Houston
- Baylor College of Medicine 4
- The Respire Institute 1
- Texas Children's Hospital & Baylor College of Medicine 1
Little Rock
- University of Arkansas for Medical Sciences 3
- Arkansas Children's Hospital 1
- University of Arkansas for Medical Sciences Hospital - University 1
Milwaukee
- Froedtert & Medical College of Wisconsin 2
- Children's Wisconsin & Medical College of Wisconsin 1
- Children's Wisconsin 1
- The Medical College of Wisconsin 1
Washington D.C.
- Children's National Hospital 2
- Children's National Medical Center 1
- MedStar Georgetown University Hospital 1
Hollywood
- Joe DiMaggio Children's Hospital 2
- Joe DiMaggio Children's Health 1
- Joe DiMaggio 1
Jacksonville
- Nemours Children's Clinic 2
- Mayo Clinic Florida 1
- Nemours Children's 1
Lebanon
- Dartmouth Hitchcock Medical Center 2
- Dartmouth-Hitchcock Geisel School of Medicine at Dartmouth 1
- Dartmouth-Hitchcock Medical Center 1
Valhalla
- New York Medical College at Westchester Medical Center 4
Spokane
- Providence Medical Group, Cystic Fibrosis Clinic 2
- Providence Medical Group, Cystic Fibrosis Clinic - Pediatrics 1
- Providence Medical Research Center 1
San Francisco
- University of California San Francisco 2
- University of California, San Francisco - Adult Center 1
- University of California, San Francisco - Peds Center 1
Rochester
- University of Rochester Medical Center Strong Memorial 3
- Mayo Clinic 1
Winston-Salem
- Southeastern Research Center 1
- Atrium Health Wake Forest Baptist Medical Center 1
- Atrium Health Wake Forest Baptist (Wake Forest Baptist) 1
- Atrium Health Wake Forest Baptist 1
Charlottesville
- University of Virginia 3
- University of Virginia Children's Hospital 1
Bethesda
- National Institutes of Health Clinical Center 3
- Suburban Hospital 1
La Jolla
- University of California San Diego 3
Long Beach
- Long Beach Memorial Medical Center 2
- Miller Children's Hospital and Long Beach Medical Center 1
Orange
- CHOC Children's Hospital 2
- Children's Hospital of Orange County 1
Sacramento
- University of California at Davis Medical Center 1
- University of California Davis Medical Center 1
- UC Davis 1
Boise
- Saint Luke's Cystic Fibrosis Center of Idaho 2
- St. Lukes CF Center of Idaho 1
Grand Rapids
- Helen DeVos Children's Hospital 2
- Corewell Health Helen DeVos 1
Billings
- Billings Clinic 2
- Billings Clinic Hospital - Public 1
New Brunswick
- Rutgers - Robert Wood Johnson Medical School 2
- Rutgers, Robert Wood Johnson Medical School 1
Dayton
- Dayton Children's Hospital 3
Oklahoma City
- Oklahoma Cystic Fibrosis Center 2
- University of Oklahoma Health Sciences Center - Pediatrics Hospital - University 1
Fort Worth
- Cook Children's Medical Center 3
Omaha
- University of Nebraska Medical Center 3
Providence
- Rhode Island Hospital 2
- Brown University Health 1
Burlington
- University of Vermont Medical Center 1
- Vermont Children's Hospital & University of Vermont Medical Center 1
- Vermont Children's Hospital 1
Buffalo
- The Cystic Fibrosis Center of Western New York 2
- University at Buffalo 1
St. Petersburg
- All Children's Hospital 2
Worcester
- University of Massachusetts Memorial Health Care 2
Morristown
- Morristown Medical Center 2
Akron
- Children's Hospital Medical Center of Akron 2
Toledo
- Toledo Children's Hospital 2
Morgantown
- West Virginia University - Morgantown 2
Lexington
- University of Kentucky 2
Detroit
- Wayne State University Harper University Hospital 2
Pensacola
- Avanza Medical Center 1
- Nemours Children's 1
Hawthorne
- New York Medical College 1
- New York Medical College/ Boston Children's Health Physicians 1
Northfield
- The Cystic Fibrosis Institute 2
San Antonio
- UT Health San Antonio 1
- The University of Texas Health Science Center at San Antonio 1
Augusta
- Augusta University 2
Wilmington
- Accellacare of Wilmington 1
- Nemours Children's 1
San Diego
- Rady Children's Hospital at University of California San Diego 1
- University of California San Diego 1
Columbia
- University of Missouri-Columbia 1
- Prisma Health Children's Hospital - Midlands 1
Bloomington
- Indiana University 2
Peoria
- OSF Saint Francis Medical Center 1
Louisville
- University of Louisville 1
Scottsdale
- HonorHealth Research Institute 1
Doral
- Omnicure Clinical Research 1
Lenexa
- Johnson County Clin-Trials (JCCT) 1
Newport Beach
- Ncfb01 50012 1
Brandon
- Ncfb01 50003 1
Plantation
- Ncfb01 50005 1
DuBois
- Ncfb01 50004 1
Rock Hill
- Ncfb01 50007 1
McKinney
- Ncfb01 50001 1
Mesquite
- Ncfb01 50010 1
Glenview
- The Cystic Fibrosis Institute 1
Anchorage
- Providence Alaska Medical Center 1
Hammond
- ASHA Clinical Research 1
Spartanburg
- Velocity Clinical Research - Spartanburg - PPDS 1
Union
- Velocity Clinical Research - Union - PPDS 1
Franklin
- Clinical Trials Center of Middle Tennessee 1
Tyler
- UT Texas Health Science at Tyler 1
Williamsburg
- TPMG Clinical Research 1
Tempe
- Celerion - Tempe 1
Overland Park
- Altasciences - Kansas City 1
Manchester
- Dartmouth Health Children's 1
Durham
- Duke University Hospital 1
Irvine
- University of California, Irvine 1
Cypress
- Cypress Innovative Breast Care Center 1
New Orleans
- Tulane University 1
Albuquerque
- University of New Mexico 1
Charlestone
- Medical University of South Carolina 1
Plano
- UT Southwestern 1
Phoenix
- Phoenix Children's Hospital 1
Tampa
- Tampa General Hospital 1
Metairie
- Tulane University 1
New Hyde Park
- Cohen Children's Medical Center of New York 1
Austin
- Dell Children's Medical Center of Central Texas 1
Fairfax
- Inova L.J. Murphy Pediatric CF Program 1
Evanston
- Northwestern University 1
Colchester
- University of Vermont 1
Syracuse
- SUNY Upstate Medical University 1
Stanford
- Stanford University 1
Lakewood
- Arthur F Gelb MD 1
🇫🇷France115
Paris
- Hôpital Pitié Salpêtrière 1
- APHP, Cochin 1
- APHP, Saint Louis 1
- APHP, Tenon 1
- Hôpital Cochin (AP-HP) 1
- AP-HP CRCM Robert debré 1
- AP-PH Hopital Cochin service de pédiatrie 1
- APHP Hopital Necker 1
- CRCM Paris 1
- Hôpital Cochin, Maternité Port-Royal, service de Gynécologie obstétrique 1
- Cmp Enfants Aphp Robert Debre - Paris 1
- Hu Paris Centre Site Cochin Aphp - Paris 14 1
Lyon
- Hôpital de la Croix Rousse, HCL, Lyon 1
- HCL- Hôpital Croix-Rousse 1
- Hospices Civils de Lyon Service de pédiatrie, allergologie et mucoviscidose 1
- CRCM Lyon 1
- Groupement Hospitalier Est Pediatric CFcenter 1
- Hospices Civils de Lyon 1
Roscoff
- Fondation Ildys 2
- Fondation ILDYS 2
- Cystic Fibrosis Resource and Competence Centre, Fondation Ildys, Roscoff 1
- Fondation Ildys, Roscoff Centre Hélio Marin - Clinique "Mucoviscidose" 1
Montpellier
- Montpellier Hospital Center 1
- CHU de Montpellier 1
- CRCM Montpellier 1
- CHU de Montpellier - Hôpital Arnaud de Villeneuve 1
- Chu Montpellier 1
Amiens
- CHU Amiens-Picardie 1
- Clinique Victor Pauchet 1
- CHU Amiens Picardie 1
- Camsp Chu Amiens 1
Marseille
- Clinique St Joseph 1
- Hôpital Européen de Marseille 1
- AP-HM CRCM pédiatrique 1
- Aphm Hopital La Timone - Marseille 1
Lille
- University Hospital 1
- CHRU de Lille CRCM Pédiatrique 1
- CRCM Lille 1
- Hôpital Calmette,CHU 1
Rouen
- CHU Rouen 1
- CRCM Mixte - Hôpital Charles Nicolle 1
- CHU de Rouen 1
- CRCM Rouen 1
Brest
- CHRU Brest 2
- Antoine VALERI 1
Créteil
- Centre hospitalier intercommunal de Créteil 1
- APHP, Henri Mondor 1
- CHI Créteil 1
Nice
- CHU H. Pasteur, Nice 1
- CHU Nice 1
- CHU de Nice 1
Toulouse
- CHU H. Larrey, Toulouse 1
- CHU Toulouse 1
- CHU de Toulouse 1
Grenoble
- CHU Grenoble-Alpes 1
- CHU de Grenoble Alpes CRCM pédiatrique 1
- CRCM Grenoble 1
Reims
- CHU Reims 1
- CRCM Reims 1
- Chu Reims 1
Vannes
- CH Bretagne Atlantique 1
- Cystic Fibrosis Resource and Competence Centre, Hospital, Tours 1
- CRCM Vannes 1
Bron
- Hôpital Femme Mère Enfant (HFME) 2
- Hopital Femme Mere Enfant - Hcl - Bron 1
Strasbourg
- Service de Pneumologie - CHU de Strasbourg - France 1
- CHU de Strasbourg 1
- Hopitaux Universitaires de Strasbour 1
Bordeaux
- CHU Haut Leveque, Bordeaux 1
- CHU de Bordeaux - CRCM pédiatrique 1
Suresnes
- Hôpital Foch, Suresnes 1
- Hôpital Foch 1
Angers
- CHU Angers 1
- Cystic Fibrosis Resource and Competence Centre, University Hospital, Angers 1
Limoges
- CHU Limoges 1
- CHU de Limoges CRCM Limousin 1
Rennes
- CHU Rennes 1
- CRCM Rennes adultes 1
Caen
- CRCM Caen 1
- PSLA GDD 1
Cergy-Pontoise
- CH Pontoise 1
Nantes
- CHU Nantes 1
Versailles
- CH Versailles 1
Villefranche-sur-Saône
- CH Villefranche s/Saône 1
Abbeville
- CH Abbeville 1
Aix-en-Provence
- CH Aix en Provence 1
Albi
- CH Albi 1
Annecy
- CH Annecy 1
Aressy
- Clinique Aressy 1
Cherbourg
- CH Cotentin 1
Compiègne
- CH Compiègne-Noyon 1
Contamine-sur-Arve
- CH Alpes-Léman 1
Dieulefit
- CFR Dieulefit 1
Hyères
- HCL - centre de Hyères 1
La Rochelle
- Groupe Hospitalier La Rochelle - Ré-Aunis 1
Le Kremlin-Bicêtre
- Hôpital Bicêtre (AP-HP) 1
Le Puy-en-Velay
- CH Le Puy-en-Velay 1
Libourne
- CH Libourne 1
Montivilliers
- Groupe Hospitalier du Havre 1
Nîmes
- CHU Nîmes 1
Pau
- CH Pau 1
Perpignan
- CH Perpignan 1
Poitiers
- CHU Poitiers 1
Saint-Quentin
- CH St Quentin 1
Tarbes
- CH Tarbes Lourdes 1
Troyes
- CH Troyes 1
Tours
- Cystic Fibrosis Resource and Competence Centre, University Hospital, Tours 1
Nancy
- CHU de Nancy 1
Giens
- CRCM Giens 1
Ivry-sur-Seine
- Marjolaine GOSSET 1
Pierre-Bénite
- Hôpital Lyon Sud 1
🇬🇧United Kingdom53
London
- Royal Brompton Hospital 4
- Royal Brompton & Harefield Hospitals, Guy's & St Thomas' NHS Foundation Trust 1
- Chest Unit Reception, King's College Hospital 1
- Royal Brompton Hospital, Department of Cystic Fibrosis (Adult) 1
Liverpool
- Liverpool Heart & Chest Hospital 2
- Liverpool University Hospitals NHS Foundation Trust - Royal Liverpool University Hospital 1
- Liverpool Heart and Chest Hospital - PPDS 1
- Liverpool Heart and Chest Hospital NHS Foundation Trust 1
- Liverpool Heart and Chest Hospital 1
Newcastle upon Tyne
- Newcastle Adult CF Centre 2
- The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Royal Victoria Infirmary 1
- The Newcastle upon Tyne Hospitals NHS Foundation Trust 1
Belfast
- Northern Ireland Clinical Research Facility (NICRF) Solo/Group Practice 1
- Queens Hospital Belfast 1
- Royal Victoria Hospital, Belfast Health and Social Care Trust 1
Glasgow
- Greater Glasgow and Clyde 1
- Queen Elizabeth University Hospital - PPDS 1
- NHS Greater Glasgow and Clyde 1
Cambridge
- Royal Papworth Hospital 1
- Royal Papworth Hospital, NHS Foundation Trust 1
- Royal Papworth Hospital NHS Foundation Trust 1
Nottingham
- Sir Peter Mansfield Imaging Centre 2
- Nottingham City Hospital 1
Birmingham
- Birmingham Heartlands Hospital 2
Edinburgh
- Royal Infirmary of Edinburgh - PPDS 1
- NHS Lothian 1
Cardiff
- Cardiff and Vale University Health Board 2
Exeter
- Royal Devon and Exeter Hospital (Wonford) 2
Leeds
- Leeds Adult CF Centre 2
Manchester
- Manchester Adult Cystic Fibrosis Centre 2
Bristol
- Medical Research Unit, Bristol Royal Infirmary 1
- Zoe Plummer 1
Dundee
- Ninewells Hospital - PPDS 1
Newcastle-under-Lyme
- Freeman Hospital 1
Bath
- Centre for Nutrition, Exercise and Metabolism 1
Blackpool
- Blackpool Teaching Hospitals 1
Oxford
- John Radcliffe Hospital 1
Southampton
- National Institute for Health Research Clinical Research Facility 1
Stoke-on-Trent
- Royal Stoke University Hospital 1
York
- York Hull Adult Cystic Fibrosis Centre 1
Sheffield
- University of Sheffield MRI Unit 1
🇮🇹Italy23
Milan
- IRCCS Ospedale San Raffaele - Endoscopia Biliopancreatica 1
- Dipartimento di Pediatria, Centro Fibrosi Cistica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico 1
- Policlinico di Milano Ospedale Maggiore | Fondazione IRCCS Ca' Granda 1
- Ospedale San Raffaele 1
Catania
- AOU Policlinico G. Rodolico - Ospedale San Marco - Broncopneumologia Pediatrica e Fibrosi Cistica Hospital - Public 1
- AOU Policlinico Gaspare Rodolico-San Marco Presidio Ospedaliero Gaspare Rodolico 1
- Azienda Ospedaliero Universitaria Policlinico G. Rodolico - San Marco 1
Genova
- IRCCS Istituto Giannina Gaslini 2
Rozzano
- Humanitas Research Hospital 1
- Istituto Clinico Humanitas 1
Florence
- Azienda Ospedaliero Universitaria Careggi - Gastroenterologia 1
- Azienda Ospedaliera Universitaria Meyer Istituto di Ricovero e Cura a Carattere Scientifico 1
Roma
- Azienda Ospedaliera Universitaria Sant'Andrea 1
- Ospedale pediatrico Bambino Gesù, IRCCS, Dipartimento Pediatrico Universitario Ospedaliero, UOC Pneumologia e Fibrosi Cistica 1
Messina
- Azienda Ospedaliero Universitaria Policlinico Gaetano Martino - Gastroenterologia Pediatrica e Fibrosi Cistica Academic / University Clinic 1
Verona
- UOC Fibrosi Cistica - AOUI Verona 1
Monza
- Fondazione IRCCS San Gerardo dei Tintori 1
Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna 1
Pavia
- Fondazione IRCCS Policlinico San Matteo 1
Bari
- Centro per la Fibrosi Cistica, Azienda Universitaria Ospedaliera Consorziale Policlinico 1
Naples
- Unità Pediatrica, Dipartimento di Scienze Mediche Traslazionali, Centro di Riferimento Regionale per la Fibrosi Cistica, Università degli Studi di Napoli Federico II 1
Torino
- Centro per la Fibrosi Cistica, Ospedale Infantile Regina Margherita 1
🇪🇸Spain18
Madrid
- Hospital Clinic De Barcelona - Cirug-ía General y Digestiva 1
- Hospital Universitario La Paz Hospital - University 1
- Hospital General Universitario Gregorio Marañon 1
- Hospital Universitario La Paz - PPDS 1
- Hospital Universitario Quironsalud Madrid 1
Barcelona
- Hospital del Mar 1
- Hospital Clinic de Barcelona 1
- Hospital Universitario Vall d'Hebron - PPDS 1
- Hospital Universitario de Bellvitge 1
Valencia
- Hospital Universitario y Politecnico La Fe - Neumología 1
- Instalaciones de la Universitat de Valencia 1
Murcia
- Universidad de Murcia - Hospital Universitario Virgen de la Arrixaca (HUVA) 1
Lleida
- Hospital Universitari Arnau de Vilanova de Lleida 1
Málaga
- H. General de Málaga - Endocrinología 1
A Coruña
- Hospital Universitario A Coruña 1
Sabadell
- Corporació Sanitària Parc Taulí 1
Seville
- Asociación Andaluza de Fibrosis Quística 1
Alcalá de Henares
- University of Alcalá 1
🇩🇪Germany18
Lübeck
- Universitätsklinikum Schleswig-Holstein 1
- Department of Gynecology and Obstetrics University Hospital Schleswig-Holstein 1
- University Children's Hospital Schleswig-Holstein 1
Giessen
- Justus-Liebig-University Giessen 1
- University Hospital Gießen and Marburg GmbH 1
Hanover
- Hannover Medical School 1
- Medizinische Hochschule Hannover 1
Heidelberg
- University of Heidelberg 1
- University Children's Hospital Heidelberg, Cystic Fibrosis Centre 1
Brandenburg an der Havel
- Klinikum Westbrandenburg 1
- Medizinische Hochschule Brandenburg (MHB), University 1
Aachen
- Medizinische Klinik V University hospital 1
München
- LMU Klinikum 1
Düsseldorf
- University Hospital Düsseldorf 1
Borstel
- National and WHO-Supranational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center 1
Essen
- Klinik für Pneumologie, Universitätsklinikum Essen 1
Cologne
- CF Study Center, University Hospital Cologne 1
Berlin
- Charité - Universitätsmedizin Berlin 1
🇨🇦Canada16
Vancouver
- British Columbia Children's Hospital 3
- CF Centre BC Children's Hospital (Vancouver, Canada) 1
- BC Children's Hospital 1
- UBC Centre for Heart Lung Innovation, St. Paul's Hospital 1
- St Paul's Hospital 1
Toronto
- The Hospital for Sick Children 1
- The Hospital for Sick Children & Toronto Canada CF Centre Pediatrics 1
- CF Centre Hospital for Sick Children (Toronto, ON) 1
- Hospital for Sick Children 1
Montreal
- Institut de recherches cliniques de Montréal 1
- Centre Hospitalier de l'Université de Montréal 1
Calgary
- University of Calgary Adult Cystic Fibrosis Clinic (Calgary, AB) 1
Halifax
- Queen Elizabeth II Hospital Halifax Adult CF Centre 1
Regina
- Saskatchewan Health Authority 1
🇨🇳China12
Guangzhou
- The First Affiliated Hospital of Guangzhou Medical University 3
- First Affiliated Hospital of Guangzhou Medical University 1
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine 1
Yixingcun
- Yixing People's Hospital, Yixing, Jiangxi Recruiting 1
- Yixing People's Hospital 1
Zhenzhou
- Huashan Hospital Fudan University 1
- Henan Infectious Disease Hospital (Zhengzhou No.6 People's Hospital) 1
Beijing
- Peking Union Medical College Hospital 2
Jinan
- The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital) 1
🇯🇵Japan11
Tokyo
- Japan Anti-Tuberculosis Association, Fukujuji Hospital 1
- Keio University Hospital 1
Chikushino-shi
- Fukuoka University Chikushi Hopsital 1
Fukuoka
- Kyusho Central Hospital of the Mutual Aid Association of Public School Teachers 1
Ibaraki
- Ibaraki Prefectural Central Hospital 1
Iizuka-shi
- Kazunori Tobino Iizuka Hospital 1
Kyoto
- National Hospital Organization Minami Kyoto Hospital 1
Mie
- Matsusaka Municipal Hospital 1
Osaka
- National Hospital Organization Kinki Chuo Chest Medical Center 1
Shimonoseki-shi
- Shimonoseki City Hospital 1
Tsu
- National Hospital Organization Mie Chuo Medical Center 1
🇪🇬Egypt8
Asyut
- Assiut university-Faculty of Medicine 3
- Assiut University hospital 1
- pediatric hospital, Assiut university 1
- Assiut unviresty - Faculty of Medicine 1
Sohag
- Sohag University Hospital 1
Cairo
- Ain Shams university 1
🇦🇺Australia6
Westmead
- Westmead Hospital 2
Queensland
- The Prince Charles Hospital 1
Canberra
- Canberra Hospital 1
Brisbane
- The Prince Charles Hospital 1
Clayton
- Monash Medical Centre 1
🇵🇱Poland5
Lodz
- Bonifraterskie Centrum Medyczne Sp. z o.o. Oddzial w Lodzi, Szpital Zakonu Bonifratrow Sw. Jana Bozego w Lodzi - Dzial Endoskopi 1
- Uniwersytet Medyczny w Łodzi Nr 1 im. Norberta Barlickiego 1
Pomorskie
- WIP Warsaw IBD Point Profesor Kierkus 1
Krakow
- Szpital Uniwersytecki w Krakowie 1
Poznan
- Uniwersytecki Szpital Kliniczny w Poznaniu 1
🇧🇬Bulgaria4
Lovech
- Medical Center Medconsult Pleven, Lovech branch 1
Pleven
- Medical Center Medconsult Pleven 1
Plovdiv
- MC Hipokrat-N - Gastroenterology 1
Sofia
- Medical Center Excelsior base 3 1
🇵🇰Pakistan4
Lahore
- Gulab Devi Chest Hospital 1
- Gulab Devi Hospital, Mayo Hospital Lahore. 1
Multan Khurd
- Nishter Hospital Multan 1
Sheikhupura
- DHQ Hospital 1
🇭🇺Hungary3
Budapest
- MH Egészségügyi Központ - Gasztroenterológiai Osztály 1
- Semmelweis Egyetem. Sebeszeti, Transzplantacios es Gasztroenterologiai Klinika - Gasztroenterologiai Osztaly 1
Csongrád
- Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar I. sz. Belgyogyaszati Klinika 1
🇵🇹Portugal3
Braga
- Centro Clínico Académico de Braga (2CA-Braga) ULS de Braga 1
Creixomil
- Hospital Senhora de Oliveira Guimarães ULS Alto Ave 1
Porto
- Instituto CUF 1
🇧🇪Belgium3
Brussels
- Cliniques Universitaires Saint-Luc 1
Jette
- UZ Brussel 1
Leuven
- University Hospitals Leuven 1
🇹🇷Turkey (Türkiye)2
Ankara
- Gulhane Faculty of Physiotherapy and Rehabilitation 1
Izmir
- Izmir Democracy University 1
🇬🇷Greece2
Athens
- Private practice, ILISION 34 15771 Athens Greece 1
Lamia
- Physiotherapy Department, University of Thessaly 1
🇷🇪Reunion2
Saint-Denis
- CHU La Réunion Félix Guyon 1
Saint-Pierre
- CHU La Réunion Sud 1
🇸🇪Sweden2
Stockholm
- Stockholm CF center 1
Gothenburg
- Department of Radiology, Queen Silvias Children´s Hospital,Gothenburg Sweden 1
🇨🇭Switzerland2
Basel
- University Hospital Basel 1
Bern
- University Children's Hospital Bern 1
🇮🇳India1
Chandigarh
- Chest clinic 1
🇯🇴Jordan1
Amman
- Stem Cells of Arabia 1
🇳🇿New Zealand1
Christchurch
- New Zealand Clinical Research 1
🇳🇴Norway1
Oslo
- Oslo University Hospital 1
🇩🇰Denmark1
Aarhus C
- Department of Infectious Diseases, Aarhus University Hospital 1
🇭🇰Hong Kong1
Hong Kong
- Chinese University of Hong 1
🇨🇿Czechia1
Olomouc
- University Hospital Olomouc 1
Source: ClinicalTrials.gov study locations, fetched 2026-11-10. Counts are trials at that site.